Forbes built a hall of shame for all the questionable people on its 30 Under 30 lists | How Anxiety Traps Us, and How We Can Break Free | You're (Maybe) Gonna Need a Patent for That Woolly Mammoth | Wall Street's dream of 'immaculate disinflation' is becoming reality and the economy is doing a lot better than people think, Nobel economist Paul Krugman says

View online | Unsubscribe (one-click). For inquiries/unsubscribe issues, Contact Us

� � � � � � Forbes built a hall of shame for all the questionable people on its 30 Under 30 lists - Business Insider    The Forbes "30 Under 30" lists celebrate the achievements of young people making a mark in a range of sectors. Unfortunately, quite a few of the picks are now a little questionable, to say the least. It's even become something of a meme, with users on X joking about federal authorities investigating those on the list. Announcing this year's lists on Tuesday, Forbes acknowledged there are some picks "we wish we could take back." Continued here � � � � � � Don't like ads? Go ad-free with TradeBriefs Premium How Anxiety Traps Us, and How We Can Break Free - Harvard Business Review    It’s normal to occasionally experience anxiety — when we’re faced with a high-stakes meeting, a stressed-out boss, or a conflict with a colleague. When we’re anxious, we tend to trap ourselves in false or limited ways of thinking. These thought patterns create a debilitating negative spiral that can take over our lives by convincing us of impending doom and further exacerbating our sense of helplessness. But there are strategies you can take to overcome these thinking traps. First, consciously change your activities to divert your attention away from your stressor. Next, give it a name, so you better understand the type of anxiety you’re dealing with. Then, separate your uncertainties from the facts, and consider what stories you’re telling yourself about the situations — and if there are other angles to consider. Finally, step outside your own head by thinking about what you would tell someone else if they were faced with the same scenario. Zulfi, a coaching client of mine, is the envy of many of his peers. As the general manager of a large, successful business, his work is one of the CEO’s core priorities. He does good work and is well-loved by his team. Continued here � � � � � � You're (Maybe) Gonna Need a Patent for That Woolly Mammoth - WIRED    The mouse didn't look like much. It had the same red beady eyes and white fur as any other laboratory mouse. Sure, its DNA had been tweaked to make it ideal for testing anti-cancer drugs, but that wasn’t so unusual either. The year was 1988, and it had been more than a decade since researchers at the Salk Institute showed it was possible to create genetically modified mice by inserting viral DNA into mouse embryos. Plenty of other genetically modified animals would be created in the following decades, but none of them would prove as important—or controversial—as OncoMouse. What made OncoMouse remarkable was its paperwork. On April 12, 1988, the US Patent and Trademark Office issued a patent for it—the first for any living animal. The patent turned a mouse—which had been modified to be more susceptible to cancer—into a legally protected invention, with a patent that prevented anyone else from making or selling mice with the same genetic tweaks. (Or, at least for the 20 or so years that most patents last.) The patent was granted to Harvard University, which passed on the exclusive license to the main funder of its research: DuPont. Soon, the chemical giant was printing T-shirts with an OncoMouse silhouette emblazoned across the chest, and selling researchers the new invention for $50 a mouse. That patent changed science forever. After OncoMouse, scientists rushed to invent—and patent—other animals that would be useful in their research. Mostly this meant mice, but occasionally other species were patented too, as in the case of rabbits engineered to be susceptible to HIV infection. OncoMouse was used in countless breast cancer studies and helped researchers understand the genetics behind human susceptibility to cancer. Continued here � � � � � � Wall Street's dream of 'immaculate disinflation' is becoming reality and the economy is doing a lot better than people think, Nobel economist Paul Krugman says - Business Insider    Wall Street's dream scenario is becoming a reality – and despite gloomy sentiment in pockets of the market, the economy is actually doing way better than people think, according to Nobel laureate Paul Krugman. The top economist recently pointed to promising signs that inflation is on the downtrend. Prices cooled to a yearly pace of 3.2% in October – well-below the highs recorded last summer, when inflation touched 9.1%.  But slowing inflation hasn't triggered a rise in unemployment or the start of a recession, pushing Wall Street closer to its dream scenario.  Though some areas of the economy are slowing, the US job market has remained resilient, with the unemployment rate clocking in at 3.9%, still close to a historic low. GDP also saw blowout growth of 5.2% last quarter, according to a revised estimate from the Commerce Department this week.  Continued here

�

�

�

� � �

You are receiving this mailer as a TradeBriefs subscriber. We fight fake/biased news through human curation & independent editorials. Your support of ads like these makes it possible. Alternatively, get TradeBriefs Premium (ad-free) for only $2/month If you still wish to unsubscribe, you can unsubscribe from all our emails here Our address is 309 Town Center 1, Andheri Kurla Road, Andheri East, Mumbai 400059 - 437931932